May 19, 2006
Patent Verdict Favors Harvard and MIT
A federal jury in Boston this month found Eli Lilly and Company liable for infringing a patent that was granted in June 2002 to Harvard University, the Massachusetts Institute of Technology, and the Whitehead Institute for Biomedical Research, and was licensed to a company called Ariad Pharmaceuticals. The verdict could lead to a multimillion-dollar payout to the academic institutions from Lilly and, eventually, additional millions from other companies, too.
The jury ordered Lilly to
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
Administration
-
The Chronicle Review
-
Short Subjects
